Why animal model studies are lost in translation

Nikolaos G. Frangogiannis

The Journal of Cardiovascular Aging ›› 2022, Vol. 2 ›› Issue (2) : 22

PDF
The Journal of Cardiovascular Aging ›› 2022, Vol. 2 ›› Issue (2) :22 DOI: 10.20517/jca.2022.10
Perspective

Why animal model studies are lost in translation

Author information +
History +
PDF

Abstract

The development of novel therapies based on understanding the pathophysiologic basis of disease is a major goal of biomedical research. Despite an explosion in new knowledge on the molecular mechanisms of disease derived from animal model investigations, translation into effective treatment for human patients has been disappointingly slow. Several fundamental problems may explain the translational failures. First, the emphasis on novel and highly significant findings selectively rewards implausible, low-probability observations and high-magnitude effects, providing a biased perspective of the pathophysiology of disease that underappreciates the complexity and redundancy of biological systems. Second, even when a sound targetable mechanism is identified, animal models cannot recapitulate the pathophysiologic heterogeneity of the human disease, and are poor predictors of therapeutic success. Third, traditional classifications of most complex diseases are based primarily on clinical criteria and do not reflect the diverse pathophysiologic mechanisms that may be involved. The development of a flexible and dynamic conceptual paradigm that takes into account the totality of the evidence on the mechanisms of disease, and pathophysiologic stratification of patients to identify subpopulations with distinct pathogenetic mechanisms, are crucial for the development of new therapeutics.

Keywords

Animal model / translation / pathophysiology / human disease

Cite this article

Download citation ▾
Nikolaos G. Frangogiannis. Why animal model studies are lost in translation. The Journal of Cardiovascular Aging, 2022, 2(2): 22 DOI:10.20517/jca.2022.10

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Housden BE,Gemberling M.Loss-of-function genetic tools for animal models: cross-species and cross-platform differences.Nat Rev Genet2017;18:24-40 PMCID:PMC5206767

[2]

Rajewsky K,Kühn R.Conditional gene targeting.J Clin Invest1996;98:600-3 PMCID:PMC507466

[3]

Frangogiannis NG.The inflammatory response in myocardial injury, repair, and remodelling.Nat Rev Cardiol2014;11:255-65 PMCID:PMC4407144

[4]

Vatner SF.Why So Few New Cardiovascular Drugs Translate to the Clinics.Circ Res2016;119:714-7 PMCID:PMC5012301

[5]

Ioannidis JP.Why most published research findings are false.PLoS Med2005;2:e124. PMCID:PMC1182327

AI Summary AI Mindmap
PDF

694

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/